Farther Finance Advisors’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.4K Sell
574
-153
-21% -$7.28K ﹤0.01% 3336
2025
Q4
$27.2K Buy
727
+386
+113% +$15.7K ﹤0.01% 3228
2025
Q3
$13.8K Buy
341
+192
+129% +$6.34K ﹤0.01% 3267
2025
Q2
$3.81K Buy
149
+85
+133% +$1.85K ﹤0.01% 3467
2025
Q1
$1.41K Hold
64
﹤0.01% 3513
2024
Q4
$1.34K Hold
64
﹤0.01% 3151
2024
Q3
$1.44K Hold
64
﹤0.01% 3119
2024
Q2
$1.09K Buy
64
+8
+14% +$129 ﹤0.01% 3042
2024
Q1
$706 Buy
56
+3
+6% +$36 ﹤0.01% 2910
2023
Q4
$614 Sell
53
-67
-56% -$756 ﹤0.01% 2909
2023
Q3
$1.53K Hold
120
﹤0.01% 1951
2023
Q2
$1.64K Buy
120
+20
+20% +$287 ﹤0.01% 1834
2023
Q1
$1.53K Hold
100
﹤0.01% 1727
2022
Q4
$1.34K Buy
+100
New +$1.34K ﹤0.01% 1575

Other funds holding PAHC

Farther Finance Advisors's PAHC Position: Q1 2026 in Review

Farther Finance Advisors reduced its Phibro Animal Health (PAHC) stake by 21% in Q1 2026, selling an estimated $7.28K and leaving 574 shares worth $31.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3336.

Farther Finance Advisors first reported a position in PAHC in Q4 2022 and has held it in 14 quarters since. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Farther Finance Advisors held 574 shares of Phibro Animal Health worth $31.4K as of Q1 2026.
  • Farther Finance Advisors sold 153 Phibro Animal Health shares in Q1 2026, an estimated $7.28K.
  • Phibro Animal Health made up ﹤0.01% of Farther Finance Advisors's portfolio in Q1 2026, its #3336 holding.
  • Farther Finance Advisors first reported a position in Phibro Animal Health in Q4 2022 and has held it in 14 quarters since.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Farther Finance Advisors's 13F filing for Q1 2026, filed 7 Apr 2026.